JBCHEPHARM.BOJBCHEPHARM.BOBSE
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+21.1%
5Y CAGR+19.8%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+21.1%/yr
vs +23.1%/yr prior
5Y CAGR
+19.8%/yr
Consistent
Acceleration
-2.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$10.32B+10.5%
2024$9.33B+32.5%
2023$7.04B+21.1%
2022$5.82B-13.5%
2021$6.72B+60.7%
2020$4.18B+20.8%
2019$3.46B+36.6%
2018$2.54B-9.6%
2017$2.81B+6.3%
2016$2.64B-